In neurons, increased protein-protein interactions between neuronal nitric oxide synthase (nNOS) and its carboxy-terminal PDZ ligand (CAPON) contribute to excitotoxicity and abnormal dendritic spine development, both of which are involved in the development of Alzheimer's disease. In models of Alzheimer's disease, increased nNOS-CAPON interaction was detected after treatment with amyloid-b in vitro, and a similar change was found in the hippocampus of APP/PS1 mice (a transgenic mouse model of Alzheimer's disease), compared with age-matched background mice in vivo. After blocking the nNOS-CAPON interaction, memory was rescued in 4-month-old APP/PS1 mice, and dendritic impairments were ameliorated both in vivo and in vitro. Furthermore, we demonstrated that S-nitrosylation of Dexras1 and inhibition of the ERK-CREB-BDNF pathway might be downstream of the nNOS-CAPON interaction.
In neurons, extrasynaptic NMDARs contain more NR2B subunits than NR2A subunits, and many cell death-signaling proteins directly or indirectly bind to NR2B subunits (Zhou, Chen, Yun & Wang, 2015) . PSD95, an adaptor of nNOS, can also link to extrasynaptic NMDARs. NR2B-rich NMDARs suppress prosurvival CREB-mediated gene expression by activating PSD95/nNOS signaling (Martel et al., 2012; Soriano et al., 2008) . However, PSD95-nNOS interaction is critical for synaptic connections (Nikonenko et al., 2008) , and therefore, prolonged suppression of PSD95-nNOS interaction may lead to unknown risks.
The carboxy-terminal PDZ ligand of nNOS (NOS1AP, also named CAPON), a scaffolding protein of nNOS that indirectly binds to NMDARs, is a risk factor in many neurological diseases, such as schizophrenia, autism, bipolar disorder, post-traumatic stress disorder, and depression (Candemir et al., 2016; Courtney, Li & Lai, 2014) . CAPON forms a complex with nNOS and transmits NO signals to other proteins related to excitotoxicity when NMDARs are activated Zhu et al., 2015) . CAPON also regulates dendritic morphology, dendrite patterning, and dendritic spine development (Candemir et al., 2016; Carrel et al., 2009; Richier et al., 2010) . Both excitotoxicity and synaptic dysfunction are major causes of Alzheimer's disease. Thus, we speculated that nNOS-CAPON interaction might be an important downstream signaling pathway of abnormal NMDAR activation in Alzheimer's disease.
We previously reported that increased nNOS-CAPON interaction induced anxiety-related behaviors via decreasing dendritic spine density and weakening prosurvival signals . In this study, we found that nNOS-CAPON interaction was increased in both amyloid-b 1-42 -treated primary cultured neurons in vitro and in the hippocampus of APP/PS1 mice. Blocking nNOS-CAPON interaction rescued neuron damage, the decrease in dendritic spines, memory loss, and prosurvival signals impaired by amyloid-b. Therefore, our work presents a potential downstream signal of amyloid b-mediated dysfunction of NMDARs.
| RESULTS

| nNOS-CAPON interaction was increased in
primary cultured hippocampal neurons treated with Ab and in the hippocampus of APP/PS1 mice As a potential ligand for NMDARs, Ab may activate NMDARs and, consequently, increase nNOS-CAPON interaction, causing pathological changes in neurons (Candemir et al., 2016; Courtney et al., 2014) . Here, we hypothesized that Ab-induced nNOS-CPAON interaction was associated with Ab neurotoxicity. Therefore, we APP/PS1 mice represent one of the most important animal models of Alzheimer's disease, and APP/PS1 mice show memory loss with age. nNOS-CAPON interaction was detected in the hippocampus of 4-month-old and 9-month-old APP/PS1 mice. Compared with aged-matched background mice, APP/PS1 mice exhibited increased nNOS-CAPON interaction in the hippocampus (Figure 1c , p < .05).
Therefore, nNOS-CAPON interaction was increased in the Alzheimer's disease model in vitro and in vivo. Subsequently, we determined whether increased nNOS-CAPON interaction contributed to Ab-mediated neurotoxicity. We constructed a peptide, named TATCAPONi, to interfere with the nNOS-CAPON interaction. TATCAPONi comprises a cell-penetrating peptide (TAT) and the 12 amino acids of the C terminal of CAPON. TAT-CAPONi selectively blocks nNOS-CAPON binding . The Ala 22 Asp mutation of TAT-CAPONi renders it incapable of binding to nNOS (Jaffrey, Snowman, Eliasson, Cohen & Snyder, 1998) . Thus, we designed a mutated peptide, TAT-CAPONi/A22D as a nonbinding control for TAT-CAPONi. In the in vitro model of Alzheimer's disease and in APP/PS1 mice, the administration of TAT-CAPONi Alzheimer's-like symptoms (Shen, Yan & He, 2016) . We pretreated C57BL/6J mice with TAT-CAPONi or TAT-CAPONi/A22D (3 nmol/g weight, i.v.) and injected fibril-Ab 1-42 into the lateral ventricles of mice after 45 min. Mice were treated with peptides at a dose of 3 nmol/g weight/day for 3 days, and their memory abilities were tested using the Morris water maze. TAT-CAPONi, TAT-CAPONi/ A22D, or vehicle was administered to mice daily during the period of the Morris water maze test (Figure 2a) . Injection of fibril-Ab into the lateral ventricles of mice induced memory deficit (Figure 2b) . There was no difference in the swimming speed of mice between groups (Fig. S2b) . Administration of TAT-CAPONi but not TAT-CAPONi/A22D prevented the memory deficit (Figure 2b ). To confirm the protective effects of uncoupling the nNOS-CAPON interaction, we repeated the above experiment with a small-molecule blocker of nNOS-CAPON binding, Zlc002 (30 mg kg À1 day
À1
, i.v.) . The results showed that Zlc002 rescued the memory loss of mice injected with Ab ( Figure 2c ).
To exclude other potential pathways influenced by TAT-CAPONi, we administered TAT-CAPONi to nNOSKO mice and then injected fibril-Ab 1-42 into the lateral ventricles of the nNOSKO mice using the same protocol as above. nNOSKO mice did not benefit from the administration of TAT-CAPONi in the Morris water maze test (Figure 2d) , suggesting that the beneficial effects of TAT-CAPONi are derived from the uncoupling nNOS and CAPON. (Fig. S2c) . Moreover, TAT-CAPONi was able to across the blood brain barrier (Fig. S3 ).
In summary, blocking nNOS-CAPON interaction rescued the memory loss in the in vivo Alzheimer's disease model.
| Blocking nNOS-CAPON interaction rescues dendritic impairments induced by Ab
Synaptic dysfunction and spine loss, but not neuron loss, are related to memory deficits in patients in the early stage of Alzheimer's disease and in young APP/PS1 mice (Herms & Dorostkar, 2016 and Synapsin I partly reflect the potency of synaptic connections (Goetzl et al., 2016) . The results showed that the densities of PSD95
and Synapsin I in the hippocampus of 4-month-old APP/PS1 mice were significantly lower than those of the background group, while 
| ERK-CREB-BDNF pathway is involved in the effects of blocking nNOS-CAPON interaction
To explore the molecular mechanisms underlying the dendritic morphology changes after nNOS-CAPON blocking, we examined ERK phosphorylation, a kinase that influences synaptic maturation and stability (Collingridge, Peineau, Howland & Wang, 2010) . TAT- In conclusion, blocking nNOS-CAPON interaction can rescue dendritic changes and inhibition of the ERK-CREB-BDNF pathway induced by Ab.
| nNOS-CAPON-Dexras1 complex and Snitrosylation of Dexras1 are related to neurotoxicity induced by Ab
In our previous study, we reported that nNOS-CAPON interaction contributed to anxiety via Dexras1 . The formation of nNOS-CAPON-Dexras1 and the S-nitrosation of Dexras1 also mediate the neurotoxicity of NMDARs (Cheah et al., 2006) Inhibition/activation of secretases of Ab generation in the amyloidogenic pathway was shown to significantly decrease the level of Ab (Parsons & Rammes, 2017) , but some forms of Ab were reported to protect the brain from infection and inflammation (Kumar et al., 2016) . In physiological conditions, some transmembrane receptors and signaling proteins are also substrates of alpha-, beta-, and gamma-secretase, key enzymes in the amyloidogenic pathway, and thus interference with the activation of secretases causes serious side effects (Parsons & Rammes, 2017) . Therefore, strategies aimed to decrease the total level of Ab may be debatable. Neutralizing toxic forms of Ab with antibodies seems to be a more direct approach than interfering with secretases, but the outcomes of clinical trials using antibody drugs showed less beneficial effects than expected (Freskgard & Urich, 2017) . Drugs are also developed to modulate Ab aggregation, but a more detailed understanding of the molecules that retard aggregate formation and of the structure-activity relationships are needed (Alam, Siddiqi, Chturvedi & Khan, 2017).
Therefore, many problems must be solved before drugs can be used to treat Alzheimer's disease by decreasing Ab or its toxic forms.
Another strategy is to reduce the toxicity of Ab based on its tar- In the present research, we focused on nNOS-CAPON interaction, which is a downstream signal of nNOS and NMDARs. According to previous studies, increased nNOS-CAPON interaction mediates excitotoxicity, overload of iron, and stress-related depressive behaviors in the brain (Courtney et al., 2014) . Under physiological conditions, CAPON regulates dendrite patterning and dendritic spine development of neurons, and Dexras1 plays important roles in the circadian clock and the responses to fluid deprivation and salt loading (Carrel et al., 2009; Cheng et al., 2004; Greenwood et al., 2016; Richier et al., 2010; Van Gelder, 2004) . These functions are associated with neither nNOS-CAPON interaction nor nNOS. Moreover, nNOS-CAPON interaction blockers used in our experiments did not affect the resting membrane potential of neurons, the
The beneficial effect of blocking the nNOS-CAPON interaction might be due to rescue of the ERK-CREB-BDNF pathway. (a) pression of spinophilin and BDNF and decreased phosphorylation of ERK and CREB in the hippocampus, and these changes were recovered by TATCAPONi (n = 6, * p < .05 compared to the 4-month-old C57BL/6J mouse group, # p < .05 compared to the 4-month-old APP/PS1 mice group). (b) Beneficial effects could be observed in vitro and were abolished with an ERK1/2 inhibitor but not with a PKA inhibitor or a TrkB inhibitor (n = 6, * p < .05 compared to the control group, # p < .05 compared to the oligo-Ab group, & p < .05 compared to the oligoAb+TAT-CAPONi group) ZHANG ET AL. 
| Cell cultures
Primary neurons were isolated from the hippocampus of mouse embryos at embryonic day 15 (E15), as previously described (Zhang et al., 2010) . Cultures were maintained in neurobasal media supplemented with B27, penicillin, streptomycin, and L-glutamine. Cells were cultured on polyornithine-coated tissue culture dishes (3.5 cm in diameter) at a density of 1 9 10 4 cells/cm 2 (morphological analysis) or 1 9 10 5 cells/cm 2 (morphological analysis). Cells were grown for 7-14 d in vitro (DIV) and used for specific experiments, as indicated below. The proportion of b-III-tubulin + cells at 10 DIV was $ 92%.
All cultures were maintained in an incubator (HERAcell 150, Thermo Fisher Scientific) with a humidified atmosphere of 95% air and 5% CO 2 at 37°C.
| Preparation of Ab 1-42 oligomers and fibrils
Oligomerized Ab 1-42 was prepared as previously reported (Brkic et al., 2015) . Briefly, Ab 1-42 was dissolved at 1 mg/ml in hexafluoroisopropanol (HFIP; Sigma-Aldrich), and the HFIP was removed after 1 hr. The peptide film was resolved at 1 mg/ml in DMSO (Sigma-Aldrich). The solution was diluted to 100 lmol/L with Ham's F-12 medium without glutamine. Then, the solution was allowed to stand for 1 hr at 25°C followed by centrifuging at 14,000 9 g for 10 min at 4°C to remove any insoluble aggregates.
For preparation of fibrils, the dried hexafluoro-2-propanol film of Ab 1-42 (see above) was dissolved in sterile PBS to yield a 3 lg/ll solution and incubated for 7 days at 37°C (De Felice et al., 2007) .
| Intrahippocampal and intracerebroventricular injections
One microliter of lentivirus (~10 6 virus particles) was bilaterally injected into the hippocampus at a rate of 0.5 ll/min. The needle was left in place for 3 min after the injection and then slowly retracted, 
| Recombinant virus production and infection
The recombinant lentivirus LV-GFP-Dexras1-C11S or its control LV-GFP was generated as we previously described .
Cultured neurons were infected with LV-GFP-Dexras1-C11S or LV-GFP containing 1.0 9 10 9 transduction units/ml at day 4 in vitro 
| Western blot analysis
Western blot analysis was performed as described previously. The primary antibodies were as follows: rabbit anti-CAPON (1:500), rabbit anti-ERK1/2 (1:500), rabbit anti-CREB (1:500), rabbit anti-nNOS
(1:1000), mouse anti-pERK1/2 (1:500), mouse anti-pCREB (1:1000), 
| Coimmunoprecipitation
Lysis and coimmunoprecipitation of cultures and tissues were performed as we previously described (Zhou et al., 2010) . Cultured neurons or hippocampal tissues were lysed in 50 mmol/L Tris-HCl (pH 7.4) in buffer containing 150 mmol/L NaCl, 1 mmol/L EDTA-Na, 1%
NP-40, 0.02% sodium azide, 0.1% SDS, 0.5% sodium deoxycholate, 1% PMSF, 1& aprotinin, 1& leupeptin, and 0.5& pepstatin A. The lysates were centrifuged at 12,000 9 g for 15 min at 4°C. The 
| Morris water maze
The spatial cognitive performance of mice was evaluated by the Morris water maze. The Morris water maze protocol has been described in detail in our previous report (Li et al., 2009) . In brief, the mouse was placed in opaque water of a circular swimming pool and trained to locate the hidden platform 0.5 cm under the surface of the water. During the training to find the hidden platform, mice were allowed to swim for a maximum of 60 s in the pool for each trial. One block of four trials per day was performed for 5 consecutive days. On the sixth day, mice performed one 60 s retention probe test during which the platform was removed from the pool.
During retention, the number of crossings of the platform location and the time spent in the target quadrant were measured.
| Biotin-switch assay
This assay was performed in the dark, as previously described (Fang et al., 2000) . according to the user manual. Briefly, the brains were first placed in impregnation solution for 2 weeks followed by 2 days in a 30% sucrose solution. Then, they were cut into 100 lm coronal sections using a vibratome (World Precision Instruments) and stained. For morphological analysis, 10 random neurons from each sample were measured, and the average was regarded as the final value of one sample.
| Immunofluorescence
The details of immunofluorescence for brain sections and cultured cells have been described . Briefly, brain slices were fixed in 4% paraformaldehyde (30 lm) and cultured cells were blocked with blocking solution (10% serum of donkey, 0.2% Triton X-100). After washing with PBS, samples were incubated with primary antibodies overnight at 4°C. Then, samples were washed with PBS and incubated with secondary antibodies (2 hr at room temperature). After washing with PBS, samples were counterstained with Hoechst 33258 (Sigma-Aldrich) to label the nuclei and mounted. Fluorescence was visualized by confocal microscopy (LSM 700, Zeiss).
The primary antibodies used were as follows: mouse/rabbit anti-GFP
(1:500), rabbit anti-Synapsin-1 (1:500), and mouse anti-PSD95
(1:500). Secondary antibodies used were goat anti-mouse Dylight 488 (1:200; Jackson ImmunoResearch) and goat anti-rabbit Cy3
(1:400; Jackson ImmunoResearch). After washing with PBS, samples were counterstained with DAPI (Sigma-Aldrich) to label the nuclei and mounted. Fluorescence was visualized by confocal microscopy.
| Congo red staining
Brain slices (30 lm) fixed in 4% paraformaldehyde were used for Congo red staining. For Congo red staining, the sections were stained in Congo red (0.5% in methanol with 20% glycerol) for 20 min, differentiated in alkaline alcohol solution, counterstained with Gill's hematoxylin for 30 s, and finally mounted with neutral gum. Congo red-stained plaques were visualized by microscopy.
| Statistical analysis
Comparisons among multiple groups were made with one-way ANOVA (one factor) or two-way ANOVA (two factors) followed by Scheff e's post hoc test. Comparisons between two groups were made with two-tailed Student's t test. Data were presented as the mean AE SEM, and p < .05 was considered statistically significant.
Investigators were blinded to the group allocation when assessing the outcomes.
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